sbn next venture, page-6

At the end of the day Kens all we're interested in is what's going to get the sp moving and so far no one is interested. I won't be putting any more money into this.All I can see with OMI is another Bio pushing another niche product in a very competitive market.One thing I can say is reading OMI post on here it seems they were cash flow positive and must have been sunk by a loss in court over a patent issue in the USA.It might be that they just need some cash injection to get things up and running again and the product will pay its way pretty quickly but I'm basing that on very little research. Cheers Mon.